Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention.
Kowalewski M, Suwalski P, Raffa GM, Słomka A, Kowalkowska ME, Szwed KA, Borkowska A, Kowalewski J, Malvindi PG, Undas A, Windyga J, Pawliszak W, Anisimowicz L, Carrel T, Paparella D, Lip GYH. Kowalewski M, et al. Among authors: windyga j. Int J Cardiol. 2016 Nov 15;223:186-194. doi: 10.1016/j.ijcard.2016.08.089. Epub 2016 Aug 4. Int J Cardiol. 2016. PMID: 27541652 Review.
Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe.
Hermans C, Astermark J, Carvalho M, Dolan G, d'Oiron R, Fontana P, Holme PA, Kenet G, Klamroth R, Mancuso ME, Marquardt N, Nunez R, Katsarou O, Pabinger-Fasching I, Quintavalle G, Rodgers R, van der Valk P, Windyga J, Jimenez Yuste V, Preložnik Zupan I. Hermans C, et al. Among authors: windyga j. Haemophilia. 2023 May;29(3):913-916. doi: 10.1111/hae.14761. Epub 2023 Feb 18. Haemophilia. 2023. PMID: 36802089 No abstract available.
Reduced left ventricular strain is related to blood parameters in patients with polycythemia vera.
Dobrowolski P, Klisiewicz A, Prejbisz A, Sikorska A, Wójcicki J, Lewandowski J, Kaszuba AM, Kabat M, Kordybach-Prokopiuk M, Więcek A, Windyga J, Januszewicz A, Hoffman P. Dobrowolski P, et al. Among authors: windyga j. Int J Cardiol. 2017 Jan 1;226:34-37. doi: 10.1016/j.ijcard.2016.10.048. Epub 2016 Oct 18. Int J Cardiol. 2017. PMID: 27783966 No abstract available.
Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society.
Kosior DA, Undas A, Kopeć G, Hryniewiecki T, Torbicki A, Mularek-Kubzdela T, Windyga J, Pruszczyk P. Kosior DA, et al. Among authors: windyga j. Kardiol Pol. 2020 Jun 25;78(6):642-646. doi: 10.33963/KP.15425. Epub 2020 Jun 8. Kardiol Pol. 2020. PMID: 32515570 Free article.
Determination and interpretation of MTHFR gene mutations in gynecology and internal medicine.
Undas A, Chojnowski K, Klukowska A, Łętowska M, Mital A, Młynarski W, Musiał J, Podolak-Dawidziak M, Sąsiadek M, Treliński J, Urasiński T, Windyga J, Zdziarska J, Zawilska K. Undas A, et al. Among authors: windyga j. Pol Arch Intern Med. 2019 Oct 30;129(10):728-732. doi: 10.20452/pamw.15039. Epub 2019 Oct 30. Pol Arch Intern Med. 2019. PMID: 31670725 Free article. Review. No abstract available.
Efficacy and safety of a recombinant factor IX (Bax326) in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open-label, uncontrolled, multicentre, phase III study.
Windyga J, Lissitchkov T, Stasyshyn O, Mamonov V, Ghandehari H, Chapman M, Fritsch S, Wong WY, Pavlova BG, Abbuehl BE. Windyga J, et al. Haemophilia. 2014 Sep;20(5):651-8. doi: 10.1111/hae.12419. Epub 2014 Apr 3. Haemophilia. 2014. PMID: 24697870 Clinical Trial.
Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level <1%) or moderately severe (FIX level ≤2%) haemophilia B.
Windyga J, Lissitchkov T, Stasyshyn O, Mamonov V, Rusen L, Lamas JL, Oh MS, Chapman M, Fritsch S, Pavlova BG, Wong WY, Abbuehl BE. Windyga J, et al. Haemophilia. 2014 Jan;20(1):15-24. doi: 10.1111/hae.12228. Epub 2013 Jul 9. Haemophilia. 2014. PMID: 23834666 Clinical Trial.
157 results